News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Onset Medicall Receives FDA Clearance to Market SoloPath(TM) Percutaneous Transseptal Access Catheter


3/14/2007 1:42:12 PM

IRVINE, Calif.--(BUSINESS WIRE)--Onset Medical Corporation announced today that the Food and Drug Administration (“FDA”) has granted clearance to begin marketing the Company’s SoloPathTM transseptal access catheter in the United States. SoloPath utilizes Onset’s patented Controlled Deployment Technology (“CDT”) to allow percutaneous access to the chambers of the left heart and surrounding vasculature.

>>> Discuss This Story


Read at BioSpace.com

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES